Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can fillers restore a youthful face after weight loss? new study investigates

NCT ID NCT07186595

Symptom relief Sponsor: AbbVie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times

Summary

This study tests whether JUVÉDERM dermal fillers can safely improve facial volume and skin quality in adults who have lost weight through medical programs. About 75 participants will receive injections in their mid-face and other areas. Researchers will measure satisfaction and track any side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
JUVÉDERM dermal fillers (hyaluronic acid injections)
What this could lead to
If it works, this could show that JUVÉDERM fillers safely improve facial volume and satisfaction for people who lose weight.
What could go wrong
This is a small, early-phase study with no comparison group. Results may not apply to everyone, and side effects like swelling or bruising are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

75 people

The number who actually took part.

Started

Sep 2025

Finished

Jul 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Must meet at least 3 of the following criteria for treatment in the face with at least 2 JUVÉDERM products, per investigator's assessment: * Minimal, moderate, or severe on Allergan Temple Hollowing Scale (ATHS) * Moderate or severe for both eyes on Allergan Infraorbital Hollow Scale (AIHS) * Moderate or severe on Allergan Cheek Smoothness Scale (ACSS) * Moderate, significant, or severe on Mid-face Volume Deficit Scale (MFVDS) * Moderate or severe on Nasolabial Fold Severity Scale (NLFSS) * Minimal, mild, or moderate on Allergan Lip Fullness Scale 2 (ALFS2) * Moderate or severe on Allergan Chin Retrusion Scale (ACRS) * Moderate or severe on Allergan Loss of Jawline Definition Scale (ALJDS) * Must be in good health as determined by subject's medical history, physical examination, and vital sign measurements. Exclusion Criteria: * Prior treatment with non-permanent soft tissue fillers or fat-reducing injectables in the face or neck within 12 months prior to screening. * Excessively loose skin in the face and/or neck. * Tendency to develop hypertrophic scarring and/or keloid scarring.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mid face volume deficit are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mid face volume deficit

Contacts and locations

Locations

  • Advanced Dermatology - Lincolnshire /ID# 277036

    Lincolnshire, Illinois, 60069, United States

  • Bellaire Dermatology Associates /ID# 278180

    Bellaire, Texas, 77401, United States

  • Delricht Research - Prytania Street - New Orleans /ID# 277039

    New Orleans, Louisiana, 70115, United States

  • H and H Research LLC /ID# 277084

    Metairie, Louisiana, 70001, United States

  • Kian Aesthetic Institute /ID# 277045

    Los Angeles, California, 90025, United States

  • Monarch Plastic Surgery and Skin Renewal Center /ID# 278182

    Atlanta, Georgia, 30328, United States

  • Pacific Clinical Innovations /ID# 277026

    Vista, California, 92083, United States

  • Skin Research Institute LLC /ID# 277038

    Coral Gables, Florida, 33146-1837, United States

  • SkinDC /ID# 277062

    Arlington, Virginia, 22209, United States

  • West Dermatology La Jolla /ID# 277034

    San Diego, California, 92121, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.